Adiponectin-expressing Treg-containing T cell fraction inhibits tumor growth in orthotopically implanted triple-negative breast cancer.

Wakana ChikaishiToshiya HigashiHirokatsu HayashiYuki HanamatsuManabu FutamuraNobuhisa MatsuhashiChiemi Saigo Tamotsu Takeuchi

Published in: Thoracic cancer (2023)

Based on our findings, the T cell fraction comprising adiponectin-expressing Tregs, represents a potential candidate for adoptive cell therapy against TNBC.

Keyphrases

cell therapy
metabolic syndrome
stem cells
insulin resistance
mesenchymal stem cells
type diabetes
skeletal muscle
wild type
risk assessment
climate change